PainReform Ltd (PRFX) - Market Capitalization

Official company branding of PainReform Corp (PRFX)

Historical price action for PainReform Ltd. (PRFX) demonstrates market performance at the level of 0.00. PainReform Ltd. (PRFX) currently has no proprietary sales, as product pricing will be determined following regulatory approval. The business focuses on creating safe opioid alternatives for postoperative pain management by optimizing pharmacokinetics. Production relies on robotic sterile lines that eliminate manual labor.

PRFX (PainReform) Market Capitalization history from 07/04/2022 to 11/12/2026
Product sample of PainReform Corp

PainReform Ltd. development of extended-release analgesics is not subject to seasonal fluctuations or macroeconomic shocks. Such stability in demand for surgical pain management should be reflected in the resilience of the assets' market valuation. The total value of all shares measures current investor confidence in the business model via the market price. Analyzing the price action allows for the separation of random price spikes from genuine trends. The company's market capitalization provides a gauge for the enterprise's long-term potential.

Key competitors

Market Value Haleon HLN|Market Value KVUE|Verona Pharma Corp - Market Capitalization|Market Valuation MENS|LGND (Ligand Pharmaceuticals) - Market Valuation|Market Capitalization AMRX|Market Value Perrigo|Alvotech S.A. - Market Valuation|Market Capitalization LQDA|GLPG (Galapagos Corp) - Market Value|Market Capitalization ANIP (ANI Pharmaceuticals)|Market Capitalization mannkindcorp.com MNKD|AMPH - Market Value|Market Value PCRX (Pacira Pharmaceuticals)|ARS Pharma (SPRY) - Market Value|Market Valuation Theravance Corp|AQST (Aquestive Therapeutics) - Market Capitalization|Market Capitalization scPharma|Market Valuation TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharma) - Market Value|Market Value China SXT Pharmaceuticals, Inc. SXTC|Eupraxia Pharmaceuticals, Inc. (EPRX) - Market Value|BHST: Market Valuation|invizyne.com - Market Value|ORMP: Market Capitalization|Entera Bio - Market Value|HYFT (MindWalk) - Market Capitalization|Market Value ABVC BioPharma, Inc ABVC|Market Value Cumberland Pharmaceuticals (CPIX)|QNTM (quantumbiopharma.com) - Market Value|Market Value FibroGen FGEN|TELO (Telomir Pharmaceuticals Inc) - Market Valuation|Rani Therapeutics Inc - Market Capitalization|SNYR - Market Capitalization|RLYB: Market Capitalization|LEXX - Market Capitalization|Market Value Pulmatrix|Market Capitalization PTHL (Pheton)|Market Value Aptorum Group Limited (APM)|LYRA (Lyra Therapeutics Inc) - Market Value|Market Capitalization IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Market Value|cbdMD Corp - Market Capitalization|Market Valuation CYTO|Lipella (LIPO) - Market Value|Market Value OptiNose Corp (OPTN)|Market Value Pieris Pharmaceuticals|PROC: Market Value|Market Value Petros Pharmaceuticals, Inc. (PTPI)|Market Valuation Qilian International Holding Group QLI|ACELYRIN, Inc. - Market Valuation|Market Value TFFP